TransGenic Group

TransGenic Group EBIT per Share

The EBIT per Share of TransGenic Group (2342.T) as of Sep 27, 2026 is 8.28 JPY. In the previous year, EBIT per Share was -38.46 JPY — a change of -121.54% (higher).

EBIT per Share

8.28JPY

YoY

-121.54%

Last updated:

EBIT per Share of TransGenic Group is 2026 8.28 JPY. EBIT per Share of TransGenic Group was 2025 -38.46 JPY. It decreases by -121.54% higher compared to the previous year.

The TransGenic Group EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
3.61 JPY
Jan 1, 2021
53.26 JPY
Jan 1, 2022
108.99 JPY
Jan 1, 2023
-18.02 JPY
Jan 1, 2024
6.20 JPY
Jan 1, 2025
-38.46 JPY
Jan 1, 2026
8.28 JPY
Jan 1, 2027 (e)
0.00 JPY
The TransGenic Group EBIT per Share history
YEAREBIT per ShareYoY
est0.00JPY-100.00%
8.28JPY-121.54%
-38.46JPY-720.51%
6.20JPY-134.39%
-18.02JPY-116.54%
108.99JPY+104.65%
53.26JPY+1,375.18%
3.61JPY-76.78%
15.55JPY+339.83%
3.54JPY-65.86%
10.36JPY+194.85%
3.51JPY+146.87%
1.42JPY-128.59%
-4.98JPY+127.58%
-2.19JPY-71.48%
-7.67JPY-4.14%
-8.00JPY-67.10%
-24.31JPY-35.15%
-37.48JPY-3.16%
-38.70JPY-3.93%
-40.29JPY—
Access this data via the Eulerpool API
Get Free API Key

TransGenic Group Stock analysis

What does TransGenic Group do? TransGenic Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TransGenic Group stock

EBIT per Share of TransGenic Group is 8.28 JPY in 2026.

EBIT per Share of TransGenic Group changed from -38.46 JPY to 8.28 JPY, representing a -121.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share TransGenic Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — TransGenic Group

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — TransGenic Group